Efficacy of Docetaxel and Oxaliplatin Regimen as a Second-Line Therapy for Patients with Advanced Pancreatic Adenocarcinoma.
Amal RayanOla N Abdel FattahAhmed SolimanHosam A HasanAsmaa M ZahranPublished in: Journal of gastrointestinal cancer (2020)
Docetaxel-oxaliplatin regimen was an active regimen in advanced cancer pancreas based on our encouraging results without occurrence of grade four toxicities.